The Irish Times

Stocktake: Short sellers are not the enemy

Shorts ‘play important role in detecting not just overpricing, but also fraud’ – study

Tue Feb 09 2021 - 05:40

Japan pension fund wrong to target short sellers

Suspending these loans will cost the GPIF about $125 million a year

Tue Dec 17 2019 - 05:00

Botox-maker back on big pharma merry-go-round

Cantillon: Abbvie seeks to broaden its base with $63bn bid for Allergan

Thu Jun 27 2019 - 05:45

Bausch & Lomb expands Waterford contact lens plant

Production lines for new lenses will create 100 jobs over the next four years

Tue Nov 13 2018 - 13:01

Short sellers: ‘unreasonably maligned’ or ‘jerks’?

Tesla chief Elon Musk is latest in long line of figures suspicious of short selling

Tue Oct 30 2018 - 05:00

Troubled emerging markets near bear market territory

Stocktake: Elon Musk taunts short sellers and GE exits Dow Jones index

Tue Jun 26 2018 - 08:00

Contact lens giant Bausch & Lomb creates 125 extra Waterford jobs

Bausch & Lomb opens €85m extension to bring total Waterford employment to 1,300

Mon Jul 31 2017 - 20:44

Milestones galore for soaring Amazon

Stocktake: Merrill Lynch research shows it’s time for investors to hold tough

Tue Apr 04 2017 - 06:30

Hedge fund manager Bill Ackman learns a $4bn lesson

Stocktake: betting the farm is always dumb – whether you make a bundle or lose the lot

Tue Mar 21 2017 - 06:30

Bausch + Lomb and Siptu agree to talks

Trade union and contact lens group to focus on talks aiming to resolve pay dispute

Tue Dec 13 2016 - 19:11

Pay row at Bausch + Lomb puts 1,250 jobs at risk

Company counters Siptu plan for work stoppages and overtime ban with warning that jobs will be cuts

Wed Dec 07 2016 - 18:09

Sales at Endo jump 18.6% on demand for generic drugs

Recently acquired Par Pharmaceuticals drives revenue but Endo still reports €200m loss

Tue Nov 08 2016 - 12:01

Drugmaker raises price of acne cream to $10,000 a tube

US pharma group accused of price gouging over huge increase in price of Aloquin

Wed Sept 21 2016 - 18:46

Allergan back on the acquisitions trail

Dublin-based Botox maker unveils €573m agreement to buy Vitae Pharmaceuticals

Sat Sept 17 2016 - 05:58

Global stock markets edge down after weak US jobs data

In Dublin Smurfit Kappa is buoyed by better-than-expected trading update

Fri May 06 2016 - 20:05

Cantillon: Valeant swipes Papa from Perrigo

What Papa brings to the party is a depth of experience from over 30 years in the business

Tue Apr 26 2016 - 01:00

Stocktake: Little evidence of anxiety over Fed’s plans

A look around the world’s stock markets

Tue Mar 29 2016 - 09:00

Cantillon: Valeant no different to other companies

The prime focus of Valeant was on maximising profit on often older drugs

Thu Mar 24 2016 - 01:00

Investors baffled by mixed messages

Aryzta and Valeant chief executives in limelight for differing yet similar reasons

Thu Mar 17 2016 - 01:00

Pharma group Shire follows Valeant down

Endo International, another Irish-headquartered specialty drugmaker, fell 23 per cent

Wed Mar 16 2016 - 18:25

Stocktake: Preparing for interest rate lift-off

Farewell to the Brics, morality and the hedge fund manager and exploiting inattention

Tue Nov 17 2015 - 08:20

Fantasy figures: when companies spin their results

Investors can be led astray by firms using non-generally accepted accounting principles

Wed Nov 04 2015 - 09:00

Joe Nocera: Valeant Pharmaceuticals looking like another Enron

Eye-popping growth and questionable acquisitions raise far too many questions

Wed Oct 28 2015 - 01:00

Hillary Clinton tweet knocks $15bn off US biotech stocks

‘Price-gouging like this . . . is outrageous’ she wrote as drug price rose from $13.50 to $750

Tue Sept 22 2015 - 01:00

Botox maker Allergan in $66bn deal with Actavis

Allergan employs about 900 here, most at its manufacturing plant in Westport

Tue Nov 18 2014 - 01:00

Pharma firms fight off aggressive suitors

Actavis must be getting dizzy from all the approaches

Thu Sept 25 2014 - 01:01

Allergan deal losing its shine for Valeant shareholders

Botox maker’s resistance an unexpected twist for Valeant

Wed Aug 20 2014 - 20:55

Valeant begins exchange offer for Botox maker Allergan

Quebec-based pharmaceutical company takes its hostile $50.8 billion bid directly to shareholders

Thu Jun 19 2014 - 07:49

Siptu meets politicians on Bausch & Lomb jobs threat

Contact lens maker wants 20 per cent pay cut on top of 200 redundancies

Mon Jun 02 2014 - 13:56

Bausch & Lomb holds all the cards

Waterford workers appear to have little leverage in battle to soften swingeing cuts

Sat May 31 2014 - 01:55

IDA tells Bausch & Lomb staff to weigh options carefully

Multinational has threatened to close Waterford plant if cost-saving measures are not accepted

Fri May 30 2014 - 17:51

Tide turns for plant that once benefited from US job cuts

Scale of cuts savage despite a certain expectation of bad news

Fri May 30 2014 - 01:00

Waterford believes job losses have hit it harder than most

TDs complains of little action to generate new employment opportunities